Pulmonary Hypertension Study: The Prostacyclin Pathway
Dr. Vallerie McLaughlin talks about the role of the prostacyclin pathway in pulmonary hypertension (PH). Dr. McLaughlin is a specialist in Cardiology and Internal Medicine at the University of Michigan Frankel Cardiovascular Center and was involved in GRIPHON, a large study of pulmonary hypertension that led to the approval of Selexipag, an oral drug for PH.
Keep updated on all the latest PH news here:Â http://bit.ly/20LXxHN
